Search Results - "TINDALL, Donald J"

Refine Results
  1. 1

    Dynamic FoxO transcription factors by Huang, Haojie, Tindall, Donald J

    Published in Journal of cell science (01-08-2007)
    “…Forkhead box O (FoxO) transcription factors FoxO1, FoxO3a, FoxO4 and FoxO6, the mammalian orthologs of Caenorhabditis elegans DAF-16, are emerging as an…”
    Get full text
    Journal Article
  2. 2

    Alternatively spliced androgen receptor variants by Dehm, Scott M, Tindall, Donald J

    Published in Endocrine-related cancer (01-10-2011)
    “…Alternative splicing is an important mechanism for increasing functional diversity from a limited set of genes. Deregulation of this process is common in…”
    Get full text
    Journal Article
  3. 3

    Regulation of FOXO protein stability via ubiquitination and proteasome degradation by Huang, Haojie, Tindall, Donald J.

    Published in Biochimica et biophysica acta (01-11-2011)
    “…Forkhead box O-class (FOXO) proteins are evolutionally conserved transcription factors. They belong to a family of proteins consisting of FOXO1, FOXO3a, FOXO4…”
    Get full text
    Journal Article
  4. 4

    Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically by RYAN, Charles J, TINDALL, Donald J

    Published in Journal of clinical oncology (20-09-2011)
    “…Discoveries over the past decade suggest that castration-resistant prostate cancer (CRPC) is sensitive, but not resistant to, further manipulation of the…”
    Get full text
    Journal Article
  5. 5

    Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex by Heemers, Hannelore V, Tindall, Donald J

    Published in Endocrine reviews (01-12-2007)
    “…Androgens, acting through the androgen receptor (AR), are responsible for the development of the male phenotype during embryogenesis, the achievement of sexual…”
    Get full text
    Journal Article
  6. 6

    Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer by Lamont, Kristin R, Tindall, Donald J

    Published in Molecular endocrinology (Baltimore, Md.) (01-06-2011)
    “…The development of stronger, more specific therapies for castration-recurrent prostate cancer depends upon gaining a more complete understanding of…”
    Get full text
    Journal Article
  7. 7

    Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer by He, Yundong, Lu, Ji, Ye, Zhenqing, Hao, Siyuan, Wang, Liewei, Kohli, Manish, Tindall, Donald J, Li, Benyi, Zhu, Runzhi, Wang, Liguo, Huang, Haojie

    Published in Nucleic acids research (28-02-2018)
    “…Abstract Androgen receptor (AR) splice variants (ARVs) are implicated in development of castration-resistant prostate cancer (CRPC). Upregulation of ARVs often…”
    Get full text
    Journal Article
  8. 8

    Are androgen receptor variants a substitute for the full-length receptor? by Lu, Ji, der Steen, Travis Van, Tindall, Donald J.

    Published in Nature reviews. Urology (01-03-2015)
    “…Key Points Truncated androgen receptor splice variants (AR-Vs) can resist androgen deprivation therapy AR-Vs have an important role in the progression of…”
    Get full text
    Journal Article
  9. 9

    Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer by Dehm, Scott M, Tindall, Donald J

    Published in Molecular endocrinology (Baltimore, Md.) (01-12-2007)
    “…The androgen receptor (AR) is a nuclear receptor transcription factor that mediates the cellular actions of androgens, the male sex steroids…”
    Get full text
    Journal Article
  10. 10

    Molecular regulation of androgen action in prostate cancer by Dehm, Scott M., Tindall, Donald J.

    Published in Journal of cellular biochemistry (01-10-2006)
    “…Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the…”
    Get full text
    Journal Article
  11. 11

    Effect of Dutasteride on the Risk of Prostate Cancer by Andriole, Gerald L, Bostwick, David G, Brawley, Otis W, Gomella, Leonard G, Marberger, Michael, Montorsi, Francesco, Pettaway, Curtis A, Tammela, Teuvo L, Teloken, Claudio, Tindall, Donald J, Somerville, Matthew C, Wilson, Timothy H, Fowler, Ivy L, Rittmaster, Roger S

    Published in The New England journal of medicine (01-04-2010)
    “…Dutasteride, an inhibitor of 5α-reductase in the prostate, was tested in a large, randomized trial to determine its ability to prevent prostate cancer. Over…”
    Get full text
    Journal Article
  12. 12

    Posttranslational modification of the androgen receptor in prostate cancer by van der Steen, Travis, Tindall, Donald J, Huang, Haojie

    “…The androgen receptor (AR) is important in the development of the prostate by regulating transcription, cellular proliferation, and apoptosis. AR undergoes…”
    Get full text
    Journal Article Book Review
  13. 13
  14. 14

    Mechanisms of Androgen-Refractory Prostate Cancer by Debes, Jose D, Tindall, Donald J

    Published in The New England journal of medicine (07-10-2004)
    “…Prostate cancer is the second-leading cause of cancer-related death among men and the seventh most common cause of death in the United States overall. Most…”
    Get full text
    Journal Article
  15. 15

    Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation by Spratt, Daniel E, Evans, Michael J, Davis, Brian J, Doran, Michael G, Lee, Man Xia, Shah, Neel, Wongvipat, John, Carnazza, Kathryn E, Klee, George G, Polkinghorn, William, Tindall, Donald J, Lewis, Jason S, Sawyers, Charles L

    Published in Cancer research (Chicago, Ill.) (15-11-2015)
    “…Clinical trials have established the benefit of androgen deprivation therapy (ADT) combined with radiotherapy in prostate cancer. ADT sensitizes prostate…”
    Get full text
    Journal Article
  16. 16

    CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage by Huang, Haojie, Regan, Kevin M., Lou, Zhenkun, Chen, Junjie, Tindall, Donald J.

    “…The function of cyclin-dependent kinase 2 (CDK2) is often abolished after DNA damage. The inhibition of CDK2 plays a central role in DNA damage--induced cell…”
    Get full text
    Journal Article
  17. 17

    Androgen receptor: past, present and future by Schmidt, Lucy J, Tindall, Donald J

    Published in Current drug targets (01-04-2013)
    “…Androgens and the androgen receptor have been the focus of prostate cancer research since the early 1940s, when Huggins and Hodges demonstrated that removal of…”
    Get more information
    Journal Article
  18. 18

    Global Methylation Profiling for Risk Prediction of Prostate Cancer by MAHAPATRA, Saswati, KLEE, Eric W, YOUNG, Charles Y. F, ZHIFU SUN, JIMENEZ, Rafael E, KLEE, George G, TINDALL, Donald J, VANAJA DONKENA, Krishna

    Published in Clinical cancer research (15-05-2012)
    “…The aim of this study was to investigate the promoter hypermethylation as diagnostic markers to detect malignant prostate cells and as prognostic markers to…”
    Get full text
    Journal Article
  19. 19

    Skp2 Inhibits FOXO1 in Tumor Suppression through Ubiquitin-Mediated Degradation by Huang, Haojie, Regan, Kevin M., Wang, Fang, Wang, Diping, Smith, David I., Jan M. A. van Deursen, Tindall, Donald J., Hershko, Avram

    “…Forkhead transcription factors FOXO1 (FKHR), FOXO3a (FKHRL1), and FOXO4 (AFX) play a pivotal role in tumor suppression by inducing growth arrest and apoptosis…”
    Get full text
    Journal Article
  20. 20

    New Developments in the Medical Management of Prostate Cancer by Kohli, Manish, MD, Tindall, Donald J., PhD

    Published in Mayo Clinic proceedings (2010)
    “…Prostate cancer is a substantial public health burden and a leading cause of cancer—related morbidity and mortality in the United States despite the…”
    Get full text
    Journal Article